In patients with oligometastatic disease, would you offer SBRT to a metastatic lymph node abutting the trachea and/or esophagus?

If so, what dose and dose constraints would you consider? How would you counsel the patient about risk of trachesophageal fistula?

Answer from: Radiation Oncologist at Academic Institution

I have treated oligometastatic lymph nodes abutting esophagus and trachea. I do not do this routinely and the risks and benefits need to be weighed in terms of whether the patient is truly oligometastatic and if there are potentially effective systemic options.For these ultracentral locations, I fav...

Comments

Radiation Oncologist at Lafayette Radiation Center
Very helpful data, thanks. The Nordic HILUS trial...

Radiation Oncologist at Cleveland Clinic
Great answer. I do believe the esophagus can tole...

Please select the option that best describes you:

In patients with oligometastatic disease, would you offer SBRT to a metastatic lymph node abutting the trachea and/or esophagus?

Related Questions